Search contract descriptions, companies and agencies.
ASTRAZENECA PHARMACEUTICALS LP
Total Committed Value of Federal Contracts
$700M
Recent Contract Actions
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Description |
Category |
Agency |
Signed |
Amount Committed |
| PRODUCTION OF COVID-19 AZD1222 VACCINE IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19) |
Drugs and Biologicals |
Department of the Army |
October 28, 2020 |
$286,927,159 |
| CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING |
Biomedical Advanced Development R&D |
Office of Assistant Secretary for Preparedness and Response - HHS |
October 21, 2020 |
$0 |
| CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING |
Biomedical Advanced Development R&D |
Office of Assistant Secretary for Preparedness and Response - HHS |
October 15, 2020 |
$0 |
| CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING |
Biomedical Advanced Development R&D |
Office of Assistant Secretary for Preparedness and Response - HHS |
October 05, 2020 |
$0 |
| THIRD NO-COST EXTENSION FOR EXPIRATION OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING |
Biomedical Advanced Development R&D |
Office of Assistant Secretary for Preparedness and Response - HHS |
September 30, 2020 |
$0 |
| EXTEND FOR EXPIRATION OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING |
Biomedical Advanced Development R&D |
Office of Assistant Secretary for Preparedness and Response - HHS |
September 15, 2020 |
$0 |
| ISSUE EXTENSION OF TARGET DATE OF DEFINITIZATION OF ADVANCED AGREEMENT FOR OTHER TRANSACTION AGREEMENT (OTA)FOR THE
COVID19 VACCINE DEVELOPMENT AND MANUFACTURING |
Biomedical Advanced Development R&D |
Office of Assistant Secretary for Preparedness and Response - HHS |
August 25, 2020 |
$0 |
| ISSUE ADVANCED AGREEMENT PRIOR TO AWARD OF AN OTHER TRANSACTION AGREEMENT (OTA)FOR THE
COVID19 VACCINE DEVELOPMENT AND MANUFACTURING |
Biomedical Advanced Development R&D |
Office of Assistant Secretary for Preparedness and Response - HHS |
May 20, 2020 |
$413,200,000 |
About this data
This data comes from the
Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the
procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a
90-day delay before it appears in the data.
